Saltar al contenido
Merck
Buscar dentro
Aplicaciones
Categoría de producto
Servicio
Área temática
Tipo de contenido
Colecciones
Idioma
Tema

Why We Use Cell Lines as Models
Why We Use Cell Lines as Models
MilliporeSigma Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power
MilliporeSigma Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
CRISPR Tools and Technologies for Accelerating Research
CRISPR Tools and Technologies for Accelerating Research
High-Throughput Microfluidic Platform for Culture of 3D-Kidney Tissue Models
High-Throughput Microfluidic Platform for Culture of 3D-Kidney Tissue Models
Photoredox Catalysis
Photoredox Catalysis
Microfluidic Devices and Systems: A Two-Part Webinar Series
Microfluidic Devices and Systems: A Two-Part Webinar Series
Lighten Up! Long-term imaging with ultra-bright, organic AIE cell trackers
Lighten Up! Long-term imaging with ultra-bright, organic AIE cell trackers
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
Página 1 de 253